1. Home
  2. KEQU vs CGEN Comparison

KEQU vs CGEN Comparison

Compare KEQU & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • CGEN
  • Stock Information
  • Founded
  • KEQU 1906
  • CGEN 1993
  • Country
  • KEQU United States
  • CGEN Israel
  • Employees
  • KEQU N/A
  • CGEN N/A
  • Industry
  • KEQU Medical Specialities
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KEQU Industrials
  • CGEN Health Care
  • Exchange
  • KEQU Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • KEQU 124.6M
  • CGEN 125.3M
  • IPO Year
  • KEQU N/A
  • CGEN 2000
  • Fundamental
  • Price
  • KEQU $42.21
  • CGEN $2.06
  • Analyst Decision
  • KEQU
  • CGEN
  • Analyst Count
  • KEQU 0
  • CGEN 0
  • Target Price
  • KEQU N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • KEQU 9.6K
  • CGEN 532.7K
  • Earning Date
  • KEQU 09-10-2025
  • CGEN 11-11-2025
  • Dividend Yield
  • KEQU N/A
  • CGEN N/A
  • EPS Growth
  • KEQU N/A
  • CGEN N/A
  • EPS
  • KEQU 4.13
  • CGEN N/A
  • Revenue
  • KEQU $263,183,000.00
  • CGEN $22,144,000.00
  • Revenue This Year
  • KEQU N/A
  • CGEN N/A
  • Revenue Next Year
  • KEQU N/A
  • CGEN $208.08
  • P/E Ratio
  • KEQU $10.03
  • CGEN N/A
  • Revenue Growth
  • KEQU 30.09
  • CGEN N/A
  • 52 Week Low
  • KEQU $30.33
  • CGEN $1.13
  • 52 Week High
  • KEQU $71.33
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 31.22
  • CGEN 65.40
  • Support Level
  • KEQU $41.32
  • CGEN $1.30
  • Resistance Level
  • KEQU $43.16
  • CGEN $2.38
  • Average True Range (ATR)
  • KEQU 1.16
  • CGEN 0.16
  • MACD
  • KEQU -0.02
  • CGEN 0.06
  • Stochastic Oscillator
  • KEQU 17.11
  • CGEN 67.33

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: